United States Biotechnology & Medical Research

Biora Therapeutics Inc (BIORQ)

Track

Track

Ticker: BIORQ Exchange: PNK
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Sarna Surbhi Non-Executive Director
Transaction date
Sale
Price
401.99
Quantity 54,987 +6.3%
Value US$4,192,045
2.6
Silvestry Damon Chief Operating Officer Officer
Transaction date
Purchase
Price
4.40
Quantity 23,746 +12.0%
Value US$104,482
2.6
Silvestry Damon Chief Operating Officer Officer
Transaction date
Purchase
Price
4.70
Quantity 34,335 +21.0%
Value US$161,374
2.6
Silvestry Damon Chief Operating Officer Officer
Transaction date
Purchase
Price
4.07
Quantity 63,870 +64.3%
Value US$259,951
1.7
Alter Jeffrey D. Non-Executive Director
Transaction date
Purchase
Price
4.85
Quantity 20,000 +109.1%
Value US$97,000
2.9
Stylli Harry Chairman & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
3.27
Quantity 152,905 +1.1%
Value US$499,999
1.7
Cooper Matthew T Chief Scientific Officer Officer
Transaction date
Purchase
Price
8.55
Quantity 9,151 +20.7%
Value US$78,241
1.7
Cooper Matthew T Chief Scientific Officer Officer
Transaction date
Purchase
Price
8.55
Quantity 99 +0.2%
Value US$846
2.9
Stylli Harry Chairman & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
8.94
Quantity 10,000 +0.1%
Value US$89,400
2.9
Stylli Harry Chairman & CEO Executive Director Large shareholder
Transaction date
Purchase
Price
15.00
Quantity 33,333 +3.3%
Value US$499,995
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-14 2022-11-09 B Purchase
Athyrium Opportunities III Co-Invest 1 LP
Large shareholder
79,711
218.18
US$1,843,479 		79,711 218.18 US$1,843,479
2022-07-05 2022-07-05 S Sale
Sarna Surbhi
Non-Executive Director
54,987 +6.3%
401.99
US$4,192,045 		54,987 +6.3% 401.99 US$4,192,045
2021-06-14 2021-06-14 B Purchase
3.3
Athyrium Opportunities Fund (A) LP
Large shareholder
99,501 +39.5%
468.28
US$1,539,297 		99,501 +39.5% 468.28 US$1,539,297
2021-06-14 2021-06-14 B Purchase
3.3
Athyrium Capital Management, LP
Large shareholder
8,097,166 +28.6%
2.47
US$20,000,000 		8,097,166 +28.6% 2.47 US$20,000,000
2020-12-17 2020-12-16 B Purchase
2.6
Silvestry Damon

Chief Operating Officer

Officer
23,746 +12.0%
4.40
US$104,482 		23,746 +12.0% 4.40 US$104,482
2020-12-17 2020-12-16 B Purchase
2.6
Silvestry Damon

Chief Operating Officer

Officer
34,335 +21.0%
4.70
US$161,374 		34,335 +21.0% 4.70 US$161,374
2020-12-16 2020-12-15 B Purchase
2.6
Silvestry Damon

Chief Operating Officer

Officer
63,870 +64.3%
4.07
US$259,951 		63,870 +64.3% 4.07 US$259,951
2020-12-15 2020-12-14 B Purchase
1.7
Alter Jeffrey D.
Non-Executive Director
20,000 +109.1%
4.85
US$97,000 		20,000 +109.1% 4.85 US$97,000
2020-12-09 2020-12-07 B Purchase
3.3
Athyrium Opportunities Fund (A) LP
Large shareholder
4,128,440 +18.1%
3.27
US$13,499,999 		4,128,440 +18.1% 3.27 US$13,499,999
2020-12-09 2020-12-07 B Purchase
3.3
Athyrium Capital Management, LP
Large shareholder
4,128,440 +18.1%
3.27
US$13,499,999 		4,128,440 +18.1% 3.27 US$13,499,999
2020-12-04 2020-12-02 B Purchase
2.9
Stylli Harry

Chairman & CEO

Executive Director Large shareholder
152,905 +1.1%
3.27
US$499,999 		152,905 +1.1% 3.27 US$499,999
2020-09-04 2020-09-03 B Purchase
1.7
Cooper Matthew T

Chief Scientific Officer

Officer
9,151 +20.7%
8.55
US$78,241 		9,151 +20.7% 8.55 US$78,241
2020-09-04 2020-09-02 B Purchase
1.7
Cooper Matthew T

Chief Scientific Officer

Officer
99 +0.2%
8.55
US$846 		99 +0.2% 8.55 US$846
2020-08-21 2020-08-19 B Purchase
2.9
Stylli Harry

Chairman & CEO

Executive Director Large shareholder
10,000 +0.1%
8.94
US$89,400 		10,000 +0.1% 8.94 US$89,400
2020-06-25 2020-06-23 B Purchase
3.3
Athyrium Capital Management, LP
Large shareholder
3,333,333 +16.7%
15.00
US$49,999,995 		3,333,333 +16.7% 15.00 US$49,999,995
2020-06-25 2020-06-23 B Purchase
3.3
Athyrium Opportunities Fund (A) LP
Large shareholder
3,333,333 +16.7%
15.00
US$49,999,995 		3,333,333 +16.7% 15.00 US$49,999,995
2020-06-23 2020-06-19 B Purchase
2.9
Stylli Harry

Chairman & CEO

Executive Director Large shareholder
33,333 +3.3%
15.00
US$499,995 		33,333 +3.3% 15.00 US$499,995
Explore more

More insider trading research around Biora Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America